Shares of CVS Caremark are climbing after the drugstore and pharmacy chain reported fourth-quarter earnings that climbed more than 12%. The company said results were boosted by pharmacy revenue at its established drugstores, which grew 6.8% during the quarter. CVS managed to fill 3.8% more prescriptions and sell more generic drugs despite processing fewer network claims and seeing a decline in store traffic. Overall, revenue in the period rose 4.6% to about $32.8 billion, beating analyst forecasts of about $32.6 billion, according to Thomson Reuters.

Brittany joined TheStreet.com TV in November 2006 after completing a degree in Journalism and Media Studies at Rutgers College. Previously, Brittany interned at the local ABC affiliate in New York City WABC-TV 7 where she helped research and produce On Your Side, a popular consumer advocacy segment.

More from Video

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Abercrombie & Fitch CEO Reveals to TheStreet How She Is Turning Company Around

Abercrombie & Fitch CEO Reveals to TheStreet How She Is Turning Company Around

The Chart Professor: Worried About United Technologies Right Here

The Chart Professor: Worried About United Technologies Right Here

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Jim Cramer: I've Liked Six Flags Entertainment Stock as an Income Producer

Jim Cramer: I've Liked Six Flags Entertainment Stock as an Income Producer